Skip to main content
Premium Trial:

Request an Annual Quote

Biolidics Raising SGD $3.1M Through Share Placements

NEW YORK— Biolidics said on Monday it plans to raise SGD$3.1 million (US$2.2 million) through a share placement round to expand the firm’s business through investments, mergers and acquisitions, joint ventures with third parties, and general working capital purposes.

As part of the share placement, the Singapore-based firm will issue about 17.9 million new ordinary shares at an issue price of $.175 per share, it said.

Biolidics’ ClearCell FX1 label-free system isolates and enriches cancer cells from blood using its single-use CTChip FR1 microfluidic chip. In December, Biolidics signed an agreement with San Carlos, California-based IncellDx to distribute the IncellDx bioINK PD-L1 CTC Core kit with the ClearCell FX 1 system. 

The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.